Skip to main content

Table 3 Descriptive statistics of included studies

From: Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA)

Article Year Country Type of HTA Methodology
Baeten [25] 2010 International (Netherlands, US, UK) Mainstream DCE
Baltussen [26] 2005 Ghana Mainstream DCE
Baltussen [27] 2007 Nepal Mainstream DCE
Bots [34] 1995 The Netherlands Very early SMART (simple attribute rating technique)
Cho [29] 2000 Korea Very early AHP
Diaby [35] 2011 Ivory Coast Mainstream DCE
Goetghebeur [36] 2012 Canada Mainstream Direct weighting, on 5-point scale
Goetghebeur [37] 2010 Canada Mainstream Direct weighting, on 5-point scale
Golan [43] 2012 Israel Mainstream PAPRIKA (Potentially All Pairwise RanKing of all possible Alternatives)
Hilgerink [30] 2011 The Netherlands Early AHP
Hummel [31] 2012 The Netherlands Early AHP
Jehu- Appiah [28] 2008 Ghana Mainstream DCE
Le Gale [38] 1990 France Mainstream Direct weighing and outranking (ELECTRE 1S Model)
Miot [39] 2011 South Africa Mainstream Direct weighting, on 5-point scale
Marsh [44] 2012 UK Mainstream DCE
Shin [32] 2008 South Korea Mainstream AHP
Sloane [33] 2003 US Mainstream AHP
Tony [40] 2010 Canada Mainstream Direct weighting, on 5-point scale
Venhorst [46] 2014 Netherlands Mainstream Direct weighting
Wilson [41] 2006 UK Mainstream Weighted benefit score (WBS)
Youngkong [42] 2011 Thailand Mainstream DCE with deliberation process
Youngkong [45] 2012 Thailand Mainstream Direct weighting with consideration of DCE results